Title: Airway Progenitor Cell Proliferation and Differentiation During Lung Repair This application responds to RFA-HL-12-006 to participate in a Consortium for the study of Lung Repair and Regeneration. The proposal seeks to establish a participating Center working closely with other national Consortium members. Our proposed Center consists of faculty led by Dr. Jeffrey Whitsett at Cincinnati Children's Hospital IVIedical Center (CCHMC) and Dr. Philip Streeter at the Oregon Health and Science University (OHSU), who have established collaborations for the study of lung biology. Our Center provides four specific aims, all focused to transcriptional mechanisms controlling proliferation and differentiation of Ainway Epithelial Cell (AEC) progenitors.
The Aims also generate and provide new antibodies, gene expression data and transgenic models of broad application to the field of Pulmonary Biology and Medicine.
Aim 1 will elucidate the role of a novel transcriptional network controlling AEC progenitors and their differentiation in conducting airways, with focus to the role of a PAX9-centered transcriptional network in the regulation of basal cell proliferation and differentiation.
Aim 2 will produce, characterize and use monoclonal and polyclonal antibodies for the identification and purification of human and mouse AECs for study of lung repair and disease.
Aim 3 will define gene expression patterns and transcriptional regulators critical for AEC homeostasis with focus to PAX9 and associated factors.
This Aim will create and standardize expression and transcriptional databases for human and mouse AECs and iPS cells induced to specific ainway cell lineages.
Aim 4 will produce novel transgenic mice for the conditional deletion and addition of genes in conducting AECs, including those related to the study of PAX9. Preliminary data accompanying this application were produced via close collaborations and interactions between members of laboratories in multiple divisions at CCHMC in the fields of Pulmonary Biology, Developmental Biology, Hematology/Oncology, and Bioinformatics, as well as those at OHSU and the Oregon Stem Cell Center. Our investigators have long-standing commitments and success related to the building and sharing of useful technologies and reagents and have been long committed to training others to advance the field of pulmonary biology and medicine.

Public Health Relevance

This UOl grant seeks to provide (1) novel insights into the molecular and cellular control of AEC progenitors and their differentiation and (2) novel reagents, tools and procedures enabling scientific advancements of value to the field of pulmonary medicine.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL110964-04
Application #
8786592
Study Section
Special Emphasis Panel (ZHL1-CSR-H (O1))
Program Officer
Blaisdell, Carol J
Project Start
2012-01-01
Project End
2016-12-31
Budget Start
2015-01-01
Budget End
2015-12-31
Support Year
4
Fiscal Year
2015
Total Cost
$586,401
Indirect Cost
$108,704
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Gokey, Jason J; Snowball, John; Sridharan, Anusha et al. (2018) MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation. JCI Insight 3:
Gokey, Jason J; Sridharan, Anusha; Xu, Yan et al. (2018) Active epithelial Hippo signaling in idiopathic pulmonary fibrosis. JCI Insight 3:
Shi, Mingjun; Flores, Brianna; Li, Peng et al. (2018) Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a ""U-shaped"" relationship. Am J Physiol Renal Physiol 314:F501-F516
Tang, Xiaofang; Snowball, John M; Xu, Yan et al. (2017) EMC3 coordinates surfactant protein and lipid homeostasis required for respiration. J Clin Invest 127:4314-4325
Gray, Jerilyn; Oehrle, Katherine; Worthen, George et al. (2017) Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection. Sci Transl Med 9:
Giridhar, Premkumar Vummidi; Bell, Sheila M; Sridharan, Anusha et al. (2016) Airway Epithelial KIF3A Regulates Th2 Responses to Aeroallergens. J Immunol 197:4228-4239
Xu, Yan; Mizuno, Takako; Sridharan, Anusha et al. (2016) Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight 1:e90558
Davies, Elizabeth R; Kelly, Joanne F C; Howarth, Peter H et al. (2016) Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life. JCI Insight 1:
Whitsett, Jeffrey A; Weaver, Timothy E (2015) Alveolar development and disease. Am J Respir Cell Mol Biol 53:1-7
Ishida, Naomasa; Fukazawa, Takuya; Maeda, Yutaka et al. (2015) A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor. Exp Cell Res 335:197-206

Showing the most recent 10 out of 32 publications